21325-1-AP

antibody from Proteintech Group

Targeting: STARD13 ARHGAP37, DLC2, GT650, LINC00464

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Immunocytochemistry (Data presented on provider website)

Antibody Data

Product number

21325-1-AP

Provider

Proteintech Group

Product name

STARD13 antibody

Antibody type

Polyclonal

Description

STARD13 antibody (Cat. #21325-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IF, WB,ELISA.

Reactivity

Human

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

20ul, 150ul

References

Submitted references

Loss of STARD13 contributes to aggressive phenotype transformation and poor prognosis in papillary thyroid carcinoma.

Zeng C, Li H, Liang W, Chen J, Zhang Y, Zhang H, Xiao H, Li Y, Guan H
Endocrine 2024 Jan;83(1):127-141

---

Circ_0003570 Suppresses the progression of hepatocellular carcinoma through miR-182-5p/STARD13 regulatory axis.

Zhang X, Chen W, Guo D, Li Y, Zhao Y, Ren M, Lu G, Lu X, He S
Biological procedures online 2022 Oct 14;24(1):14

---

MiR-125b enhances doxorubicin-induced cardiotoxicity by suppressing the nucleus-cytoplasmic translocation of YAP via targeting STARD13.

Jin X, Yu W, Ye P
Environmental toxicology 2022 Apr;37(4):730-740

---

Role of exosomal microRNA-125b-5p in conferring the metastatic phenotype among pancreatic cancer cells with different potential of metastasis.

Wu M, Tan X, Liu P, Yang Y, Huang Y, Liu X, Meng X, Yu B, Wu Y, Jin H
Life sciences 2020 Aug 15;255:117857